Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by King, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 77-80
© 2001 The British Society for Antimicrobial Chemotherapy


Supplement

Recommendations for susceptibility tests on fastidious organisms and those requiring special handling

Anna King1,*

1 Microbiology Department, GKT School of Medicine, St Thomas' Hospital, London SE1 7EH, UK

Abstract

Fastidious organisms present problems in antimicrobial susceptibility testing related to particular cultural requirements or slow growth. Methods for commonly isolated fastidious organisms, including haemolytic streptococci, Neisseria spp. and Haemophilus spp., are included in the description of the standardized disc diffusion method. However, some further information is given here for Haemophilus influenzae and Neisseria spp. Other less commonly isolated fastidious organisms are detailed and modifications of the disc diffusion method are given for Campylobacter spp. and rapidly growing anaerobes. For those organisms where disc diffusion methodology is not recommended, Brucella spp., Helicobacter pylori and Leigionella spp., MIC determinations are often needed, although disc diffusion test results may be useful as screens for resistance. Where disc diffusion can be used it is important to use the correct medium and to include appropriate controls. Methodology is also given for testing isolates of Stenotrophomonas maltophilia, which are affected by both medium and temperature.

Notes

* Tel: +44-20-7928-9292; Fax: +44-20-7928-0730; E-mail: anna.king{at}kcl.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Med MicrobiolHome page
M. Anoushiravani, T. Falsafi, and V. Niknam
Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori
J. Med. Microbiol., October 1, 2009; 58(10): 1309 - 1313.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. R. Evans, G. Northey, T. S. Sarvotham, A. L. Hopkins, C. J. Rigby, and D. Rh. Thomas
Risk factors for ciprofloxacin-resistant Campylobacter infection in Wales
J. Antimicrob. Chemother., August 1, 2009; 64(2): 424 - 427.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
Y.-D. Wu, L.-H. Chen, X.-J. Wu, S.-Q. Shang, J.-T. Lou, L.-Z. Du, and Z.-Y. Zhao
Gram Stain-Specific-Probe-Based Real-Time PCR for Diagnosis and Discrimination of Bacterial Neonatal Sepsis
J. Clin. Microbiol., August 1, 2008; 46(8): 2613 - 2619.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. M. Andrews and for the BSAC Working Party on Susceptibility Testi
BSAC standardized disc susceptibility testing method (version 5)
J. Antimicrob. Chemother., September 1, 2006; 58(3): 511 - 529.
[Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. Gibreel and D. E. Taylor
Macrolide resistance in Campylobacter jejuni and Campylobacter coli
J. Antimicrob. Chemother., August 1, 2006; 58(2): 243 - 255.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. D. Brown, M. M. Traczewski, and the Brucella QC Working Group
Broth Microdilution Susceptibility Testing of Brucella Species: Quality Control Limits for Ten Antimicrobial Agents against Three Standard Quality Control Strains
J. Clin. Microbiol., November 1, 2005; 43(11): 5804 - 5807.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. J. Lawson, N. C. Elviss, and R. J. Owen
Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales
J. Antimicrob. Chemother., August 1, 2005; 56(2): 282 - 286.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
N. C. Elviss, R. J. Owen, J. Xerry, A. M. Walker, and K. Davies
Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales
J. Antimicrob. Chemother., August 1, 2004; 54(2): 435 - 440.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
D. M. Livermore, S. Alexander, B. Marsden, D. James, M. Warner, E. Rudd, and K. Fenton
Activity of ertapenem against Neisseria gonorrhoeae
J. Antimicrob. Chemother., July 1, 2004; 54(1): 280 - 281.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. M. Best, D. J. M. Haldane, M. Keelan, D. E. Taylor, A. B. R. Thomson, V. Loo, C. A. Fallone, P. Lyn, F. M. Smaill, R. Hunt, et al.
Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods
Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3138 - 3144.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. M. Andrews, J. P. Ashby, G. Jevons, and R. Wise
In vitro susceptibility of ertapenem by BSAC standardized methodology
J. Antimicrob. Chemother., October 1, 2003; 52(4): 733 - 734.
[Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
B. Ge, S. Bodeis, R. D. Walker, D. G. White, S. Zhao, P. F. McDermott, and J. Meng
Comparison of the Etest and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter
J. Antimicrob. Chemother., October 1, 2002; 50(4): 487 - 494.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
P. J Jenks
Causes of failure of eradication of Helicobacter pylori
BMJ, July 6, 2002; 325(7354): 3 - 4.
[Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
Z. Samra, H. Shmuely, Y. Niv, G. Dinari, D. J. Passaro, A. Geler, E. Gal, M. Fishman, J. Bachor, and J. Yahav
Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime
J. Antimicrob. Chemother., June 1, 2002; 49(6): 1023 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C. McNulty, and the PHLS Helicobacter Working Group:, R. Owen, D. Tompkins, P. Hawtin, K. McColl, A. Price, G. Smith, and L. Teare
Helicobacter pylori susceptibility testing by disc diffusion
J. Antimicrob. Chemother., April 1, 2002; 49(4): 601 - 609.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.